Clinical Trials on Glabellar Crease
Total 10000 results
-
Spanish Breast Cancer Research GroupPierre Fabre Laboratories; Puma Biotechnology, Inc.Active, not recruitingHER2 Positive Breast Cancer | Hormone Receptor Positive | Early-stage Breast CancerSpain
-
Stanford UniversityCalifornia Breast Cancer Research ProgramCompletedDepression | Post-traumatic Stress Disorder | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States, Puerto Rico
-
Emory UniversityNational Cancer Institute (NCI)TerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States
-
Montefiore Medical CenterAlbert Einstein College of Medicine; Deciphera Pharmaceuticals LLCTerminatedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast AdenocarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnStage 0 Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | HER2/Neu Negative | PostmenopausalUnited States
-
Hospital Clinic of BarcelonaFundació La Marató de TV3RecruitingPrehabilitation | Breast Cancer Early Stage Breast Cancer (Stage 1-3)Spain
-
Henan Cancer HospitalRecruiting
-
Region Örebro CountyRecruitingNeoadjuvant Therapy | Shared Decision Making | Breast Cancer Early Stage Breast Cancer (Stage 1-3)Sweden
-
University of Wisconsin, MadisonContext Therapeutics Inc.TerminatedMetastatic Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | HER2/Neu PositiveUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast CarcinomaUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI); United States Department of Defense and other collaboratorsRecruitingBreast Cancer | Breast Cancer Screening | Breast Carcinoma in SituUnited States
-
University of LouisvilleTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage IIA | Breast Cancer, Invasive Ductal | Invasive Mammary CarcinomaUnited States
-
Cukurova UniversityCompletedWell-being | Newborn Diseases | Breast Milk Collection | MİNDFULNESSTurkey (Türkiye)
-
Endomagnetics IncM.D. Anderson Cancer CenterCompleted
-
National Cancer Institute (NCI)RecruitingBreast Carcinoma | Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEdema | Erythema | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Recurrent Inflammatory Breast Carcinoma | Stage IV Inflammatory Breast Carcinoma | Peau d'OrangeUnited States
-
Mayo ClinicCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)Active, not recruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Zagazig UniversityCompletedEarly Breast Cancer | Arm Lymphedema | Lymphatic Spread of Breast CancerEgypt
-
National Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerCanada
-
Dana-Farber Cancer InstituteCompletedStage I Breast Carcinoma | Stage II Breast CarcinomaUnited States
-
Massachusetts General HospitalRecruitingBreast Reductions | Drain Output After Breast Reduction SurgeryUnited States
-
Danone NutriciaCompletedBreast Feeding | Breast Milk ExpressionChina
-
European Institute of OncologyCompletedBreast Reconstruction | Radiation Therapy Complication | Prepectoral Breast ReconstructionItaly
-
Sun Yat-sen UniversityNot yet recruitingAdvanced/Metastatic Breast Cancer | HER2+, Low, or Ultralow Advanced/Metastatic Breast CancerChina
-
Tianjin Medical University Cancer Institute and...Southwest Hospital, ChinaNot yet recruitingTNBC - Triple-Negative Breast Cancer | PD-L1 Positive
-
Tianjin Medical University Cancer Institute and...Not yet recruitingTriple Negative Breast Cancer (TNBC) | PD-L1 PositiveChina
-
Smart Breast Corp.National Cancer Institute (NCI); University of Texas, Southwestern Medical...Not yet recruitingBreast Neoplasm | Biopsy | Molecular Imaging | Dense Breasts | Breast Cancer DetectionUnited States
-
Wang JiayuCancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruitingVinorelbine | Liposomal Doxorubicin | Her2-negative Metastatic Breast Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Chung Shan Medical UniversityPhytofound Biotech Co., Ltd.Not yet recruiting
-
Institut CurieSeagen Inc.RecruitingHER2-positive Breast CancerFrance
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Fudan UniversityRecruitingHormone Receptor Positive HER-2 Negative Breast CancerChina
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
Second Affiliated Hospital, School of Medicine,...Affiliated Hangzhou First People's Hospital, Zhejiang UniversityNot yet recruitingBreast Neoplasm Female | Breast Reconstruction | Wound ComplicationChina
-
Yonsei UniversityRecruitingBreast Cancer Classified as TNM Stage 0-IIIaSouth Korea
-
Assiut UniversityNot yet recruitingRole of MRI in Evaluation of Breast Cancer
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
MedSIRHoffmann-La RocheActive, not recruitingHER2-positive Breast CancerUnited States, Spain, Germany, France, Italy
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Abramson Cancer Center at Penn MedicineActive, not recruitingBreast Cancer Stage IIBUnited States
-
University of Kansas Medical CenterActive, not recruitingHER2-positive Breast CancerUnited States
-
Ottawa Hospital Research InstituteCompleted
-
ETOP IBCSG Partners FoundationPfizer; Hoffmann-La RocheCompletedBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorFrance, Switzerland, Belgium, Italy